nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—PGR—ovarian cancer	0.402	0.613	CbGaD
Norgestimate—ESR1—ovarian cancer	0.254	0.387	CbGaD
Norgestimate—ABCC2—Paclitaxel—ovarian cancer	0.0664	0.312	CbGbCtD
Norgestimate—ABCC2—Carboplatin—ovarian cancer	0.0625	0.294	CbGbCtD
Norgestimate—ABCC2—Docetaxel—ovarian cancer	0.048	0.226	CbGbCtD
Norgestimate—ABCC2—Doxorubicin—ovarian cancer	0.0358	0.168	CbGbCtD
Norgestimate—PGR—corpus luteum—ovarian cancer	0.0157	0.214	CbGeAlD
Norgestimate—PGR—ovarian follicle—ovarian cancer	0.0123	0.167	CbGeAlD
Norgestimate—ESR1—ovarian follicle—ovarian cancer	0.00958	0.131	CbGeAlD
Norgestimate—PGR—oviduct—ovarian cancer	0.00538	0.0736	CbGeAlD
Norgestimate—ESR1—oviduct—ovarian cancer	0.00421	0.0576	CbGeAlD
Norgestimate—PGR—myometrium—ovarian cancer	0.00172	0.0235	CbGeAlD
Norgestimate—PGR—epithelium—ovarian cancer	0.00135	0.0185	CbGeAlD
Norgestimate—ESR1—myometrium—ovarian cancer	0.00135	0.0184	CbGeAlD
Norgestimate—PGR—uterine cervix—ovarian cancer	0.00134	0.0183	CbGeAlD
Norgestimate—ESR1—embryo—ovarian cancer	0.0013	0.0177	CbGeAlD
Norgestimate—PGR—decidua—ovarian cancer	0.00128	0.0175	CbGeAlD
Norgestimate—PGR—endometrium—ovarian cancer	0.00121	0.0166	CbGeAlD
Norgestimate—PGR—uterus—ovarian cancer	0.00112	0.0153	CbGeAlD
Norgestimate—ESR1—epithelium—ovarian cancer	0.00106	0.0145	CbGeAlD
Norgestimate—ESR1—uterine cervix—ovarian cancer	0.00105	0.0143	CbGeAlD
Norgestimate—PGR—female reproductive system—ovarian cancer	0.001	0.0137	CbGeAlD
Norgestimate—ESR1—decidua—ovarian cancer	0.000999	0.0137	CbGeAlD
Norgestimate—ESR1—endometrium—ovarian cancer	0.000948	0.013	CbGeAlD
Norgestimate—PGR—female gonad—ovarian cancer	0.000914	0.0125	CbGeAlD
Norgestimate—PGR—vagina—ovarian cancer	0.000908	0.0124	CbGeAlD
Norgestimate—ESR1—gonad—ovarian cancer	0.000879	0.012	CbGeAlD
Norgestimate—ESR1—uterus—ovarian cancer	0.000874	0.0119	CbGeAlD
Norgestimate—ABCC2—female reproductive system—ovarian cancer	0.000863	0.0118	CbGeAlD
Norgestimate—PGR—testis—ovarian cancer	0.00081	0.0111	CbGeAlD
Norgestimate—ESR1—female reproductive system—ovarian cancer	0.000785	0.0107	CbGeAlD
Norgestimate—ESR1—female gonad—ovarian cancer	0.000715	0.00977	CbGeAlD
Norgestimate—ESR1—vagina—ovarian cancer	0.00071	0.00971	CbGeAlD
Norgestimate—ABCC2—testis—ovarian cancer	0.000696	0.00952	CbGeAlD
Norgestimate—ESR1—testis—ovarian cancer	0.000634	0.00866	CbGeAlD
Norgestimate—Ethynodiol—PGR—ovarian cancer	0.000619	0.109	CrCbGaD
Norgestimate—PGR—lymph node—ovarian cancer	0.000587	0.00803	CbGeAlD
Norgestimate—Norelgestromin—PGR—ovarian cancer	0.000584	0.103	CrCbGaD
Norgestimate—Allylestrenol—PGR—ovarian cancer	0.000584	0.103	CrCbGaD
Norgestimate—Desogestrel—PGR—ovarian cancer	0.000563	0.0993	CrCbGaD
Norgestimate—ABCC2—lymph node—ovarian cancer	0.000505	0.0069	CbGeAlD
Norgestimate—ESR1—lymph node—ovarian cancer	0.000459	0.00628	CbGeAlD
Norgestimate—Etonogestrel—PGR—ovarian cancer	0.000455	0.0803	CrCbGaD
Norgestimate—Ethynodiol—ESR1—ovarian cancer	0.000391	0.0689	CrCbGaD
Norgestimate—Allylestrenol—ESR1—ovarian cancer	0.000369	0.0651	CrCbGaD
Norgestimate—Desogestrel—ESR1—ovarian cancer	0.000355	0.0627	CrCbGaD
Norgestimate—Levonorgestrel—PGR—ovarian cancer	0.000322	0.0568	CrCbGaD
Norgestimate—Etonogestrel—ESR1—ovarian cancer	0.000287	0.0507	CrCbGaD
Norgestimate—Norethindrone—PGR—ovarian cancer	0.000261	0.0461	CrCbGaD
Norgestimate—Levonorgestrel—ESR1—ovarian cancer	0.000203	0.0359	CrCbGaD
Norgestimate—PGR—Gene Expression—WDR77—ovarian cancer	0.000156	0.00299	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—MMP2—ovarian cancer	0.000155	0.00298	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	0.000154	0.00295	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000153	0.00295	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000153	0.00293	CbGpPWpGaD
Norgestimate—Progesterone—PGR—ovarian cancer	0.000152	0.0268	CrCbGaD
Norgestimate—PGR—Signaling by ERBB4—ESR1—ovarian cancer	0.000148	0.00284	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—IL6ST—ovarian cancer	0.000145	0.0028	CbGpPWpGaD
Norgestimate—Progesterone—CYP1B1—ovarian cancer	0.000142	0.0251	CrCbGaD
Norgestimate—ESR1—Estrogen signaling pathway—AKT1—ovarian cancer	0.000142	0.00273	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000139	0.00268	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—ovarian cancer	0.000138	0.00266	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000135	0.0026	CbGpPWpGaD
Norgestimate—Testosterone—CYP1B1—ovarian cancer	0.000134	0.0237	CrCbGaD
Norgestimate—PGR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000131	0.00252	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000131	0.00251	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CXCL8—ovarian cancer	0.000129	0.00247	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000128	0.00245	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000126	0.00243	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—MYC—ovarian cancer	0.000126	0.00243	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000126	0.00242	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—MYC—ovarian cancer	0.000124	0.00238	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PIK3CD—ovarian cancer	0.000123	0.00236	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—TTF1—ovarian cancer	0.000122	0.00234	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	0.00012	0.00231	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CCND1—ovarian cancer	0.00012	0.00231	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—MTOR—ovarian cancer	0.00012	0.0023	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—ovarian cancer	0.000119	0.00229	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HSD17B6—ovarian cancer	0.000119	0.00228	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000118	0.00227	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000117	0.00226	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000116	0.00222	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000115	0.00221	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000115	0.00221	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ovarian cancer	0.000112	0.00216	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000112	0.00216	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—CDKN1B—ovarian cancer	0.000112	0.00216	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—ERBB2—ovarian cancer	0.000112	0.00215	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—NR5A1—ovarian cancer	0.000111	0.00213	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—MTOR—ovarian cancer	0.000111	0.00213	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—IL2—ovarian cancer	0.00011	0.00211	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00011	0.00211	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.00011	0.00211	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—ovarian cancer	0.000109	0.0021	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—ERBB2—ovarian cancer	0.000109	0.00209	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000109	0.00209	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000108	0.00208	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL2—ovarian cancer	0.000107	0.00206	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PIK3CB—ovarian cancer	0.000107	0.00206	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—MTOR—ovarian cancer	0.000107	0.00206	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—CCND1—ovarian cancer	0.000107	0.00206	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000107	0.00205	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000105	0.00202	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CCND1—ovarian cancer	0.000105	0.00201	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000104	0.00199	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—TP53—ovarian cancer	0.000102	0.00196	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—MMP9—ovarian cancer	0.000102	0.00195	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ovarian cancer	0.000101	0.00194	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—DLC1—ovarian cancer	0.000101	0.00194	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—PTEN—ovarian cancer	0.000101	0.00194	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—CDKN1B—ovarian cancer	0.000101	0.00193	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—CCND1—ovarian cancer	9.9e-05	0.0019	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—MAPK3—ovarian cancer	9.9e-05	0.0019	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	9.79e-05	0.00188	CbGpPWpGaD
Norgestimate—Progesterone—ESR1—ovarian cancer	9.6e-05	0.0169	CrCbGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	9.48e-05	0.00182	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	9.48e-05	0.00182	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—MAPK1—ovarian cancer	9.42e-05	0.00181	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	9.31e-05	0.00179	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PTEN—ovarian cancer	9.26e-05	0.00178	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	9.23e-05	0.00177	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—WDR77—ovarian cancer	9.13e-05	0.00175	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	9.02e-05	0.00173	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ovarian cancer	8.93e-05	0.00172	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—MAPK3—ovarian cancer	8.83e-05	0.0017	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—MYC—ovarian cancer	8.59e-05	0.00165	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	8.55e-05	0.00164	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	8.54e-05	0.00164	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	8.41e-05	0.00162	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	8.4e-05	0.00161	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	8.39e-05	0.00161	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.33e-05	0.0016	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—NRAS—ovarian cancer	8.26e-05	0.00159	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—BCL9—ovarian cancer	8.24e-05	0.00158	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	8.17e-05	0.00157	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—MAPK3—ovarian cancer	7.91e-05	0.00152	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	7.77e-05	0.00149	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	7.7e-05	0.00148	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	7.59e-05	0.00146	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—MAPK1—ovarian cancer	7.53e-05	0.00145	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—EGFR—ovarian cancer	7.52e-05	0.00145	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	7.47e-05	0.00144	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	7.24e-05	0.00139	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	7.21e-05	0.00139	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—TTF1—ovarian cancer	7.16e-05	0.00138	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—KRAS—ovarian cancer	7.11e-05	0.00137	CbGpPWpGaD
Norgestimate—Norethindrone—ABCB1—ovarian cancer	7e-05	0.0124	CrCbGaD
Norgestimate—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	6.98e-05	0.00134	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	6.89e-05	0.00132	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	6.83e-05	0.00131	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	6.73e-05	0.00129	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PIK3CA—ovarian cancer	6.53e-05	0.00125	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—DOK1—ovarian cancer	6.52e-05	0.00125	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NR5A1—ovarian cancer	6.5e-05	0.00125	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	6.37e-05	0.00122	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	6.32e-05	0.00121	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—YAP1—ovarian cancer	6.32e-05	0.00121	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	6.31e-05	0.00121	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	6.29e-05	0.00121	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	6.29e-05	0.00121	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	6.25e-05	0.0012	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	6.24e-05	0.0012	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PPP1CC—ovarian cancer	6.13e-05	0.00118	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—ESR1—ovarian cancer	6.12e-05	0.00118	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—HRAS—ovarian cancer	6.04e-05	0.00116	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	5.96e-05	0.00114	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—DLC1—ovarian cancer	5.93e-05	0.00114	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	5.9e-05	0.00113	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	5.81e-05	0.00112	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—IL6—ovarian cancer	5.78e-05	0.00111	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	5.66e-05	0.00109	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	5.6e-05	0.00108	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.56e-05	0.00107	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	5.51e-05	0.00106	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	5.46e-05	0.00105	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	5.43e-05	0.00104	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.37e-05	0.00103	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—AKT1—ovarian cancer	5.33e-05	0.00103	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	5.31e-05	0.00102	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	5.18e-05	0.000995	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—PARP1—ovarian cancer	5.13e-05	0.000986	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	4.93e-05	0.000948	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.91e-05	0.000944	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	4.85e-05	0.000931	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—BCL9—ovarian cancer	4.84e-05	0.000929	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.82e-05	0.000926	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.69e-05	0.000901	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.64e-05	0.000892	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HDAC6—ovarian cancer	4.64e-05	0.000892	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	4.64e-05	0.000892	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	4.54e-05	0.000872	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.53e-05	0.00087	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	4.44e-05	0.000853	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	4.44e-05	0.000853	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	4.42e-05	0.000849	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	4.42e-05	0.000848	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.24e-05	0.000814	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	4.19e-05	0.000806	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	4.17e-05	0.000802	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—PPP2R1A—ovarian cancer	4.16e-05	0.0008	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—YAP1—ovarian cancer	4.11e-05	0.000789	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.09e-05	0.000785	CbGpPWpGaD
Norgestimate—Progesterone—ABCB1—ovarian cancer	4.08e-05	0.0072	CrCbGaD
Norgestimate—PGR—Signaling Pathways—XIAP—ovarian cancer	4.03e-05	0.000773	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SMARCA4—ovarian cancer	3.92e-05	0.000754	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.87e-05	0.000743	CbGpPWpGaD
Norgestimate—Testosterone—ABCB1—ovarian cancer	3.86e-05	0.00681	CrCbGaD
Norgestimate—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	3.83e-05	0.000736	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EREG—ovarian cancer	3.83e-05	0.000736	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—DOK1—ovarian cancer	3.82e-05	0.000735	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.76e-05	0.000723	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	3.73e-05	0.000716	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—YAP1—ovarian cancer	3.71e-05	0.000713	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.68e-05	0.000707	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.68e-05	0.000707	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	3.6e-05	0.000691	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	3.55e-05	0.000681	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.47e-05	0.000668	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—IL6—ovarian cancer	3.39e-05	0.000652	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PARP1—ovarian cancer	3.34e-05	0.000641	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PGR—ovarian cancer	3.24e-05	0.000622	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.19e-05	0.000613	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—MYC—ovarian cancer	3.18e-05	0.000612	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	3.15e-05	0.000605	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	3.13e-05	0.000602	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.09e-05	0.000593	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PARP1—ovarian cancer	3.01e-05	0.000578	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—ESR1—ovarian cancer	2.95e-05	0.000566	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HDAC6—ovarian cancer	2.72e-05	0.000524	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PPP2R1A—ovarian cancer	2.71e-05	0.00052	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.61e-05	0.000501	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PPP2R1A—ovarian cancer	2.44e-05	0.000469	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—YAP1—ovarian cancer	2.41e-05	0.000463	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—XIAP—ovarian cancer	2.36e-05	0.000454	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	2.3e-05	0.000442	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EREG—ovarian cancer	2.25e-05	0.000432	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TERT—ovarian cancer	2.15e-05	0.000413	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PGR—ovarian cancer	2.11e-05	0.000405	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CAV1—ovarian cancer	1.99e-05	0.000382	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PARP1—ovarian cancer	1.96e-05	0.000376	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ESR1—ovarian cancer	1.92e-05	0.000368	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL6ST—ovarian cancer	1.88e-05	0.000362	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	1.87e-05	0.000359	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CG—ovarian cancer	1.81e-05	0.000348	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—APC—ovarian cancer	1.81e-05	0.000348	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CD—ovarian cancer	1.59e-05	0.000306	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.59e-05	0.000305	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—MAPK3—ovarian cancer	1.58e-05	0.000303	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—MYC—ovarian cancer	1.53e-05	0.000294	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ERBB2—ovarian cancer	1.41e-05	0.00027	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CB—ovarian cancer	1.39e-05	0.000267	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MTOR—ovarian cancer	1.39e-05	0.000267	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCL8—ovarian cancer	1.33e-05	0.000256	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN1B—ovarian cancer	1.3e-05	0.00025	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CASP3—ovarian cancer	1.28e-05	0.000245	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL2—ovarian cancer	1.27e-05	0.000245	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TERT—ovarian cancer	1.26e-05	0.000242	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CCND1—ovarian cancer	1.24e-05	0.000239	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CTNNB1—ovarian cancer	1.23e-05	0.000236	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MMP9—ovarian cancer	1.21e-05	0.000232	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PTEN—ovarian cancer	1.2e-05	0.00023	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CAV1—ovarian cancer	1.17e-05	0.000224	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL6ST—ovarian cancer	1.11e-05	0.000213	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—ovarian cancer	1.08e-05	0.000208	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STAT3—ovarian cancer	1.07e-05	0.000206	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NRAS—ovarian cancer	1.07e-05	0.000206	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	1.06e-05	0.000204	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—APC—ovarian cancer	1.06e-05	0.000204	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—AKT1—ovarian cancer	1.06e-05	0.000204	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MAPK3—ovarian cancer	1.02e-05	0.000197	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MYC—ovarian cancer	9.96e-06	0.000191	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MAPK1—ovarian cancer	9.75e-06	0.000187	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EGFR—ovarian cancer	9.75e-06	0.000187	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	9.34e-06	0.00018	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—MAPK3—ovarian cancer	9.25e-06	0.000178	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KRAS—ovarian cancer	9.21e-06	0.000177	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—MYC—ovarian cancer	8.99e-06	0.000173	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CA—ovarian cancer	8.46e-06	0.000163	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ERBB2—ovarian cancer	8.25e-06	0.000159	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—ovarian cancer	8.18e-06	0.000157	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MTOR—ovarian cancer	8.14e-06	0.000156	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	8.14e-06	0.000156	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL8—ovarian cancer	7.83e-06	0.00015	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HRAS—ovarian cancer	7.83e-06	0.00015	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	7.64e-06	0.000147	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CASP3—ovarian cancer	7.49e-06	0.000144	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL6—ovarian cancer	7.49e-06	0.000144	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL2—ovarian cancer	7.48e-06	0.000144	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCND1—ovarian cancer	7.29e-06	0.00014	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	7.22e-06	0.000139	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MMP9—ovarian cancer	7.08e-06	0.000136	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PTEN—ovarian cancer	7.04e-06	0.000135	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKT1—ovarian cancer	6.91e-06	0.000133	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—ovarian cancer	6.36e-06	0.000122	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STAT3—ovarian cancer	6.29e-06	0.000121	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NRAS—ovarian cancer	6.28e-06	0.000121	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—AKT1—ovarian cancer	6.24e-06	0.00012	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MAPK3—ovarian cancer	6.01e-06	0.000116	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MYC—ovarian cancer	5.85e-06	0.000112	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MAPK1—ovarian cancer	5.72e-06	0.00011	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EGFR—ovarian cancer	5.72e-06	0.00011	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KRAS—ovarian cancer	5.4e-06	0.000104	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	4.96e-06	9.54e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—ovarian cancer	4.8e-06	9.23e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HRAS—ovarian cancer	4.59e-06	8.83e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL6—ovarian cancer	4.4e-06	8.45e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKT1—ovarian cancer	4.06e-06	7.79e-05	CbGpPWpGaD
